Targeting matrix metalloproteinase-14 disrupts DNA repair and reduces viability in adrenocortical carcinoma

Changxian Shen(The Ohio State University), Priya H. Dedhia(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
bioRxiv (Cold Spring Harbor Laboratory)
January 7, 2026
10.64898/2026.01.06.697992
Cited by 0

Related Papers

Differential ability of Tribbles family members to promote degradation of C/EBPα and induce acute myelogenous leukemia
|Blood|2010|149
Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cells
|Scientific Reports|2017|47
P53 suppresses ribonucleotide reductase via inhibiting mTORC1
|Oncotarget|2017|38
A 3D adrenocortical carcinoma tumor platform for preclinical modeling of drug response and matrix metalloproteinase activity
|Scientific Reports|2023|18
KRAS-induced STN1 (OBFC1) promotes proper CTC1–STN1–TEN1 complex-independent DNA double-strand break repair and cell cycle checkpoint maintenance in pancreatic cancer
|Nucleic Acids Research|2025|2